At Qualthera, we’re redefining how proven therapies reach patients by repurposing underused or off-patent drugs and optimizing how they're delivered. Backed by real-world data, clinical insight, and advanced technology, our approach accelerates development while reducing cost and risk—so patients with chronic or hard-to-treat conditions don’t have to wait. Our flagship innovation, a patent-pending biodegradable CBD implant, aims to be the first FDA-approved solution of its kind, offering long-acting relief for pain and neurodegenerative disorders. As a division of Qualthera Health Corporation, and led by Donald Prentiss and a cross-functional team, we bridge personalized care and scalable innovation to deliver one mission: quality therapy for life.